NEX 1285
Alternative Names: NEX1285Latest Information Update: 26 Apr 2007
At a glance
- Originator Nextran
- Class
- Mechanism of Action Immunosuppressants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Xenotransplant rejection
Most Recent Events
- 26 Apr 2007 No development reported - Preclinical for Xenotransplant rejection in USA (unspecified route)
- 17 Oct 2003 Preclinical trials in Xenotransplant rejection in USA (unspecified route)